{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:04:02Z","timestamp":1781078642096,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Health Policy OPEN"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.hpopen.2026.100166","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:06:56Z","timestamp":1771952816000},"page":"100166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Exploring changes to financial protection and equity in Lithuania following 2017\u20132020 policies to improve access to outpatient medicines"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6625-8843","authenticated-orcid":false,"given":"Liubov\u0117","family":"Murauskien\u0117","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3824-8226","authenticated-orcid":false,"given":"Marina","family":"Karanikolos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpopen.2026.100166_b0005","unstructured":"WHO Regional Office for Europe. Can people afford to pay for health care? Evidence on financial protection in 40 countries in Europe. World Health Organization, Regional Office for Europe, Copenhagen, 2023 (available from https:\/\/www.who.int\/europe\/publications\/i\/item\/WHO-EURO-2023-8969-48741-72485 accessed 23\/06\/2025)."},{"issue":"37","key":"10.1016\/j.hpopen.2026.100166_b0010","article-title":"Monitoring progress towards universal health coverage in Europe: a descriptive analysis of financial protection in 40 countries","volume":"12","author":"Thomson","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.hpopen.2026.100166_b0015","unstructured":"Kacevi\u010dius G, Karanikolos M. The impact of the crisis on the health system and health in Lithuania (in Maresso A, Mladovsky P, Thomson S, et al., editors: Economic crisis, health systems and health in Europe: Country experience) Copenhagen, European Observatory on Health Systems and Policies, WHO Regional Office for Europe, 2015 (available from https:\/\/eurohealthobservatory.who.int\/publications\/i\/economic-crisis-health-systems-and-health-in-europe-country-experience-study accessed 23\/06\/2025)."},{"issue":"12","key":"10.1016\/j.hpopen.2026.100166_b0020","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.healthpol.2016.09.006","article-title":"de Joncheere K (2016) Policy interventions related to medicines: survey of measures taken in European countries during 2010-2015","volume":"120","author":"Vogler","year":"2016","journal-title":"Health Policy"},{"key":"10.1016\/j.hpopen.2026.100166_b0025","unstructured":"National Audit Office. Is accessibility to reimbursed generic medicines ensured? [in Lithuanian]. Vilnius, 2016 (available from https:\/\/www.valstybeskontrole.lt\/LT\/Product\/23610\/ar-uztikrinamas-kompensuojamuju-generiniu-vaistu-prieinamumas accessed 23\/06\/2025)."},{"key":"10.1016\/j.hpopen.2026.100166_b0030","unstructured":"Murauskien\u0117 L, Thomson S. Can people afford to pay for health care? New evidence on financial protection in Lithuania. World Health Organization Regional Office for Europe, Copenhagen, 2018 (available from https:\/\/iris.who.int\/bitstream\/handle\/10665\/329455\/9789289053143-eng.pdf?sequence=1&isAllowed=y accessed 23\/06\/2025)."},{"key":"10.1016\/j.hpopen.2026.100166_b0035","unstructured":"OECD\/European Observatory on Health Systems and Policies. Lithuania: country health profile 2025. State of health in the EU. OECD\/European Observatory on Health Systems and Policies, Paris \/ Brussels, 2025."},{"key":"10.1016\/j.hpopen.2026.100166_b0040","unstructured":"Eurostat. Database: healthcare expenditures. 2025. (available from https:\/\/ec.europa.eu\/eurostat\/databrowser\/view\/hlth_sha11_hchf__custom_15192628\/default\/table?lang=en accessed 23\/06\/2025)."},{"issue":"9","key":"10.1016\/j.hpopen.2026.100166_b0045","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2471\/BLT.18.209031","article-title":"Catastrophic health spending in Europe: equity and policy implications of different calculation methods","volume":"96","author":"Cylus","year":"2018","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.hpopen.2026.100166_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.healthpol.2024.105136","article-title":"Assessing the equity and coverage policy sensitivity of financial protection indicators in Europe","volume":"147","author":"Cylus","year":"2024","journal-title":"Health Policy"},{"key":"10.1016\/j.hpopen.2026.100166_b0055","unstructured":"UHC Watch. Tracking progress on affordable access to health care in Europe and central Asia. 2025. WHO Barcelona Office for Health Systems Financing (available from https:\/\/apps.who.int\/dhis2\/uhcwatch\/#\/ accessed 23\/06\/2025)."},{"key":"10.1016\/j.hpopen.2026.100166_b0060","series-title":"Health system performance assessment: A framework for policy analysis","first-page":"2022","article-title":"Chapter 7. Service delivery","author":"Nolte","year":"2022"},{"key":"10.1016\/j.hpopen.2026.100166_b0065","unstructured":"Statistics Lithuania. Household budget survey. 2022. (available from https:\/\/osp.stat.gov.lt\/informaciniai-pranesimai?articleId=10297442 accessed 23\/06\/2025)."},{"key":"10.1016\/j.hpopen.2026.100166_b0070","unstructured":"Statistics Lithuania. Open data. 2025. (available from https:\/\/atviri-duomenys.stat.gov.lt\/ accessed 23\/06\/2025)."},{"issue":"2","key":"10.1016\/j.hpopen.2026.100166_b0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172753","article-title":"Affordability of medicines in the European Union","volume":"12","author":"Zaprutko","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.hpopen.2026.100166_b0080","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s40258-019-00509-z","article-title":"Financial burden of prescribed medicines included in outpatient benefits package schemes: comparative analysis of co-payments for reimbursable medicines in european countries","volume":"17","author":"Vogler","year":"2019","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.hpopen.2026.100166_b0085","unstructured":"European Parliament. Resolution on EU options for improving access to medicines 2016\/2057. 2017. (available from https:\/\/www.europarl.europa.eu\/doceo\/document\/TA-8-2017-0061_EN.pdf accessed 23\/06\/2025)."},{"key":"10.1016\/j.hpopen.2026.100166_b0090","unstructured":"European Parliament. Addressing shortages of medicines. 2020. (available from https:\/\/www.europarl.europa.eu\/RegData\/etudes\/BRIE\/2020\/649402\/EPRS_BRI(2020)649402_EN.pdf accessed 23\/06\/2025)."},{"key":"10.1016\/j.hpopen.2026.100166_b0095","unstructured":"World Health Organization. Addressing the global shortage of, and access to, medicines and vaccines. 2020. Report by the Director-General (available from https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/EB142\/B142_13-en.pdf accessed 23\/06\/2025)."},{"key":"10.1016\/j.hpopen.2026.100166_b0100","unstructured":"NHIF. Response to a frequently asked question about co-payments for medicines: why does my neighbour pay less? National Health Insurance Fund [In Lithuanian]. 2025. (available from https:\/\/ligoniukasa.lrv.lt\/lt\/naujienos\/atsake-i-dazniausia-klausima-apie-vaistu-priemokas-kodel-kaimynas-moka-maziau\/accessed 23\/06\/2025)."},{"key":"10.1016\/j.hpopen.2026.100166_b0105","unstructured":"Ministry of Health. Order of the Minister of Health on the approval of guidelines for medicines policy. Vilnius, Ministry of Health of the Republic of Lithuania. 2017. (available from https:\/\/e-seimas.lrs.lt\/portal\/legalAct\/lt\/TAD\/98cdbf608c8111e7a5e2b345b086d377?jfwid=mm accessed 23\/06\/2025)."},{"issue":"4","key":"10.1016\/j.hpopen.2026.100166_b0110","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/0020852318815330","article-title":"Managing pharmaceutical shortages: an overview and classification of policy responses in Europe and the USA","volume":"86","author":"Beck","year":"2019","journal-title":"Int Rev Adm Sci"},{"key":"10.1016\/j.hpopen.2026.100166_b0115","unstructured":"CPME. CPME Policy on Medicine Shortages. The Standing Committee of European Doctors. 2020. (available from https:\/\/www.cpme.eu\/policies-and-projects\/pharmaceuticals-and-healthcare\/access-medicines-and-shortages accessed 23\/06\/2025)."},{"key":"10.1016\/j.hpopen.2026.100166_b0120","doi-asserted-by":"crossref","unstructured":"Vogler S, Paris V, Ferrario A, et al. How can pricing and reimbursement policies improve affordable access to medicines? Lessons Learned from European Countries. Appl Health Econ Health Policy. 2017 Jun;15(3):307-321. doi: 10.1007\/s40258-016-0300-z.","DOI":"10.1007\/s40258-016-0300-z"},{"key":"10.1016\/j.hpopen.2026.100166_b0125","unstructured":"EMA. Availability of Medicines for human use: Lithuania. European Medicines Association. 2025. (available from https:\/\/www.hma.eu\/human-medicines\/availability-of-medicines.html accessed 23\/06\/2025)."},{"key":"10.1016\/j.hpopen.2026.100166_b0130","unstructured":"SMCA. Disruptions in supply of medicines. State Medicines Control Agency [in Lithuanian]. 2023. (available from https:\/\/vvkt.lrv.lt\/lt\/vaistiniu-preparatu-tiekimo-sutrikimai\/ accessed 23\/06\/2025)."},{"key":"10.1016\/j.hpopen.2026.100166_b0135","unstructured":"National Audit Office. State audit report on accessibility of medicines to residents in 2023. National Audit Office [in Lithuanian]. 2023. (available from https:\/\/www.valstybeskontrole.lt\/LT\/Product\/24211\/vaistu-prieinamumas-gyventojams accessed 23\/06\/2025)."},{"key":"10.1016\/j.hpopen.2026.100166_b0140","unstructured":"NHIF. Consumption of reimbursed medicines in 2023. National Health Insurance Fund. 2023. (available from https:\/\/ligoniukasa.lrv.lt\/media\/viesa\/saugykla\/2024\/6\/R3zwkbQgl1M.pdf accessed 23\/06\/2025)."},{"key":"10.1016\/j.hpopen.2026.100166_b0145","article-title":"Good practice guidance for communication to the public on medicines\u2019 availability issues","author":"EMA","year":"2024","journal-title":"European Medicines Agency"},{"key":"10.1016\/j.hpopen.2026.100166_b0150","article-title":"Household_budget_survey_-_statistics_on_consumption_expenditure","author":"Eurostat","year":"2025","journal-title":"European Commission"},{"key":"10.1016\/j.hpopen.2026.100166_b0155","unstructured":"Statistics Lithuania. Statistical indicators. 2025. (available from https:\/\/osp.stat.gov.lt\/statistiniu-rodikliu-analize#\/ accessed 23\/06\/2025)."},{"key":"10.1016\/j.hpopen.2026.100166_b0160","unstructured":"European Observatory on Health Systems and Policies. COVID-19 health systems response monitor. 2021. (available from https:\/\/eurohealthobservatory.who.int\/monitors\/hsrm\/hsrm-countries\/hsrm\/lithuania accessed 23\/06\/2025)."},{"key":"10.1016\/j.hpopen.2026.100166_b0165","unstructured":"Parliament of the Republic of Lithuania. Law on value added tax Nr. IX-751 (2017 amendment Nr. XIII-817) [in Lithuanian]. 2002. Official gazette, Vilnius (available from https:\/\/e-seimas.lrs.lt\/portal\/legalAct\/lt\/TAD\/TAIS.163423\/asr accessed 23\/06\/2025)."},{"key":"10.1016\/j.hpopen.2026.100166_b0170","unstructured":"Minister of Health. Order on the approval of the lists of reimbursed medicines. [in Lithuanian]. 2000. Ministry of Health, Vilnius (available from https:\/\/www.e-tar.lt\/portal\/lt\/legalAct\/TAR.FA9CC3E1430C\/asr accessed 23\/06\/2025)."},{"key":"10.1016\/j.hpopen.2026.100166_b0175","unstructured":"Ministry of Health. Order of the Minister of Health on the approval of pharmaceutical policy guidelines [in Lithuanian] Official gazette, Vilnius. 2017. (available from https:\/\/e-seimas.lrs.lt\/portal\/legalAct\/lt\/TAD\/98cdbf608c8111e7a5e2b345b086d377?jfwid=-xs7urpbxx&fbclid=IwAR0jStm4KXR3juFDpokVgLyTETcN7XeU87_rtADrEIR1mRf7QTN1RurNcEA accessed 23\/06\/2025)."},{"key":"10.1016\/j.hpopen.2026.100166_b0180","unstructured":"Parliament of the Republic of Lithuania. Health insurance law Nr. I-1343 (2019 amendment Nr. XIII-2492) [in Lithuanian] Official gazette, Vilnius. 1996. (available from https:\/\/e-seimas.lrs.lt\/portal\/legalAct\/lt\/TAD\/TAIS.28356\/asr accessed 23\/06\/2025)."}],"container-title":["Health Policy OPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590229626000067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590229626000067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:43:51Z","timestamp":1781077431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590229626000067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":36,"alternative-id":["S2590229626000067"],"URL":"https:\/\/doi.org\/10.1016\/j.hpopen.2026.100166","relation":{},"ISSN":["2590-2296"],"issn-type":[{"value":"2590-2296","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring changes to financial protection and equity in Lithuania following 2017\u20132020 policies to improve access to outpatient medicines","name":"articletitle","label":"Article Title"},{"value":"Health Policy OPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpopen.2026.100166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100166"}}